EcoDrugPlus

Ribosomal Protein S28

Ensembl ID : ENSKMAG00000015763
Gene Symbol: RPS28
3 Cross references
274 Possible Orthologues:

Ribosomal Protein S3a

Ensembl ID : ENSKMAG00000004638
Gene Symbol: RPS3A
4 Cross references
360 Possible Orthologues:

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSKMAG00000014895
Gene Symbol: RPS4X
2 Cross references
465 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSKMAG00000012994
Gene Symbol: RPS5
3 Cross references
264 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSKMAG00000018438
Gene Symbol: RPS8
3 Cross references
325 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSKMAG00000005101
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSKMAG00000000169
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSKMAG00000008998
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSKMAG00000010527
Gene Symbol: LOC108249882
3 Cross references
191 Possible Orthologues:

Serine/threonine-Protein Kinase Chk2-Like

Ensembl ID : ENSKMAG00000005850
Gene Symbol: LOC108248076
3 Cross references
205 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSKMAG00000008261
Gene Symbol: LOC108233008
3 Cross references
246 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSKMAG00000006864
Gene Symbol: SERPINC1
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).